• Nie Znaleziono Wyników

Diagnosis of cardiac structural changes: Utility of altered gadolinium kinetics on cardiac magnetic resonance

N/A
N/A
Protected

Academic year: 2022

Share "Diagnosis of cardiac structural changes: Utility of altered gadolinium kinetics on cardiac magnetic resonance"

Copied!
1
0
0

Pełen tekst

(1)

LETTER TO THE EDITOR

Cardiology Journal 2014, Vol. 21, No. 1, p. 100 DOI: 10.5603/CJ.2014.0010 Copyright © 2014 Via Medica ISSN 1897–5593

100 www.cardiologyjournal.org

Diagnosis of cardiac structural changes:

Utility of altered gadolinium kinetics on cardiac magnetic resonance

We read with great interest the article by Dwi- vedi et al. [1] entitled “Progressive breathlessness in an Afro Caribbean hypertensive subject”, which was published in the previous issue of ”Cardiology Journal”.

They aimed to show diagnostic utility of hyper- -enhancement patterns on cardiac magnetic reso- nance (CMR) in differentiating a range of structural changes that manifest as increased wall thickness.

They also mentioned that primary cardiac amylo- idosis could not be excluded on the basis of the T1 mapping findings. This case highlights the diagno stic abilities of CMR in questionable cases, yet we have some comments about the article.

In addition to the enhancement pattern, myo- cardial tagging magnetic resonance images can show any active displacement and deformation of tags in regions conflicting with septal hypertrophy.

In amyloid patients, differences in T1 between subepicardium, myocardium, subendocardium, and blood are present. Gadolinium washout from blood and myocardium is significantly faster in amyloid

patients, resulting in a higher blood T1 over time [2, 3].

In conclusion, late gadolinium enhancement provides incremental information for differentia- ting a range of structural changes. Subendocardial T1 over time is significantly lower than blood and myocardium ones, and diagnosis can be established using the combination of enhancement pattern and subendocardial-blood T1 difference with > 90%

concordance.

Conflict of interest: none declared References

1. Dwivedi G, MacFadyen RJ, Varma C, Sharma V, Neil D, Steeds RP.

Progressive breathlessness in an Afro Caribbean hypertensive subject. Cardiol J, 2012; 19: 646–649.

2. Hombach V, Merkle N, Bernhard P, Rasche V, Rottbauer W.

Prognostic significance of cardiac magnetic resonance imaging:

Update 2010. Cardiol J, 2010; 17: 549–557.

3. Maceira AM, Joshi J, Prasad SK et al. Cardiovascular magnetic re- sonance in cardiac amyloidosis. Circulation, 2005; 111: 186–193.

Emre Yalcinkaya1, Baris Bugan2, Murat Celik1, Uygar Cagdas Yuksel1

1Gulhane Military Medical Faculty, Department of Cardiology, GATA Etlik 06018 Ankara, Turkey, tel: +903123044257, fax: +903123044250, e-mail: dremreyalcinkaya@gmail.com

2Malatya Army Hospital, Department of Cardiology, Malatya, Turkey

Cytaty

Powiązane dokumenty

Background: Therapeutic hypothermia and targeted temperature management are considered stand- ard of care in the management of patients following out-of-hospital cardiac arrests due

Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol, 2010;

An infarction of this wall resulted in a necrosis vector directed forward that explained a tall R wave in V1–V2 as a mirror- -image of a Q wave recorded in posterior leads..

Current European Society of Cardiology and American Heart Association guidelines high- light the importance of echocardiography for the assessment of aortic regurgitation (AR),

Aortic regurgitation assessment by cardiovascular magnetic resonance imaging and transthoracic echocardi- ography: intermodality disagreement impacting on prediction of post-sur-

Spośród tych powikłań badanie rezonansu magne- tycznego serca (ang. cardiac magnetic resonance – CMR) ma znaczenie głównie w przypadku powikłań mechanicz- nych, tętniaka serca

Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of

Key words: myocardial fibrosis, diffuse systemic sclerosis, cardiac magnetic resonance